Zurcher Kantonalbank (Zurich Cantonalbank) I Mab Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$8.27 - $18.43 $56,955 - $126,927	-6,887 Reduced 75.1%	2,284 $26,000
Q1 2022 Apr 21, 2022	SELL	$12.54 - $46.93 $17,957 - $67,203	-1,432 Reduced 13.51%	9,171 $149,000
Q4 2021 Feb 01, 2022	SELL	$45.28 - $74.5 $355,402 - $584,750	-7,849 Reduced 42.54%	10,603 $502,000
Q3 2021 Nov 15, 2021	BUY	$57.18 - $84.43 $280,982 - $414,889	4,914 Added 36.3%	18,452 $1.34 Million
Q2 2021 Jul 30, 2021	BUY	$47.86 - $83.95 $592,937 - $1.04 Million	12,389 Added 1078.24%	13,538 $1.14 Million
Q1 2021 May 03, 2021	BUY	$44.38 - $63.97 $50,992 - $73,501	1,149 New	1,149 $56,000

Others Institutions Holding IMAB

# of Institutions

Shares Held

15.5M

Call Options Held

56.4K

Put Options Held

5.8K

Hhlr Advisors, Ltd. Grand Cayman, E9

6.91M
Shares

$7.25 Million
0.2% of portfolio
Decheng Capital Management Iii (Cayman), LLC

4.17M
Shares

$4.38 Million
3.04% of portfolio
Boothbay Fund Management, LLC New York, NY

1.42M
Shares

$1.49 Million
0.05% of portfolio
Temasek Holdings (Private) LTD Singapore, U0

567K
Shares

$594,982
0.0% of portfolio
David A. Siegel Two Sigma Advisers, LP | New York, Ny

499K
Shares

$524,265
0.0% of portfolio

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $87.3M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account